Ranitidine

Ranitidine is a pharmaceutical-grade active ingredient classified as an H₂ Receptor Antagonist Antiulcer agent. Mediocon Inc supplies high-purity Ranitidine API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Ranitidine is an H2-receptor antagonist that competitively inhibits histamine at the H2 receptors of gastric parietal cells, reducing basal and stimulated acid secretion. It is used in the treatment of peptic ulcers, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. Ranitidine HCl is the pharmaceutical salt form widely used in tablet and injection formulations.

Key Features

• High-purity pharmaceutical grade API
• IP/BP/EP/USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• Duodenal and gastric ulcer treatment
• GERD and erosive esophagitis
• Zollinger-Ellison syndrome
• Prevention of stress-related mucosal bleeding

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings